UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 222

Sortiert nach

Characterization of nitrotyrosine as a biomarker for arthritis and joint injury

Osteoarthritis and cartilage, 2013-01, Vol.21 (1), p.151-156

2013

Volltextzugriff (PDF)

(413) Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability of extended-release oxycodone with sequestered naltrexone (ALO-02) in healthy volunteers: a comparison of ALO-02 40 mg twice daily to OxyContin 40 mg twice daily and ALO-02 80 mg once daily

The journal of pain, 2014-04, Vol.15 (4), p.S79-S79

2014

Volltextzugriff (PDF)

(411) Abuse potential study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) compared with immediate-release oxycodone and placebo when crushed and administered intranasally to non-dependent, recreational opioid users

The journal of pain, 2014-04, Vol.15 (4), p.S78-S78

2014

Volltextzugriff (PDF)

(409) Evaluation of the effects of food and of sprinkling pellets on applesauce on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended-release formulation of oxycodone with sequestered naltrexone

The journal of pain, 2014-04, Vol.15 (4), p.S78-S78

2014

Volltextzugriff (PDF)

(410) Efficacy and safety of ALO-02, an extended-release oxycodone surrounding sequestered naltrexone, in the treatment of moderate-to-severe chronic low back pain

The journal of pain, 2014-04, Vol.15 (4), p.S78-S78

2014

Volltextzugriff (PDF)

(412) Abuse potential study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) compared with immediate-release oxycodone administered orally to non-dependent, recreational opioid users

The journal of pain, 2014-04, Vol.15 (4), p.S79-S79

2014

Volltextzugriff (PDF)

Efficacy and safety of tanezumab in the treatment of chronic low back pain

Pain (Amsterdam), 2011-10, Vol.152 (10), p.2248-2258

2011

Volltextzugriff (PDF)

FRI0046 Characterization of nitrotyrosine as a clinical biomarker for arthritis and joint injury

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.324-325

2013

Volltextzugriff (PDF)

Efficacy and safety of subcutaneous tanezumab in patients with pain related to diabetic peripheral neuropathy (NCT01087203)

The journal of pain, 2013-04, Vol.14 (4), p.S68-S68

2013

Volltextzugriff (PDF)

Long-term safety and efficacy of tanezumab as treatment for chronic low back pain (NCT00924664)

The journal of pain, 2013-04, Vol.14 (4), p.S68-S68

2013

Volltextzugriff (PDF)

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

Pain (Amsterdam), 2013-07, Vol.154 (7), p.1009-1021

2013

Volltextzugriff (PDF)

Lack of a pharmacokinetic interaction between azithromycin and chloroquine

The American journal of tropical medicine and hygiene, 2006-03, Vol.74 (3), p.407

2006

Volltextzugriff (PDF)

Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene

British journal of clinical pharmacology, 2007-01, Vol.63 (1), p.59-66

2007

Volltextzugriff (PDF)

Tanezumab, an Anti-Nerve Growth Factor (NGF) antibody, for the treatment of chronic low back pain (CLBP) – a randomized, controlled, double-blind, phase 2 trial

The journal of pain, 2009-04, Vol.10 (4), p.S42-S42

2009

Volltextzugriff (PDF)

A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment

Pain (Amsterdam), 2015-09, Vol.156 (9), p.1660-1669

2015

Volltextzugriff (PDF)

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users

Pain medicine (Malden, Mass.), 2017-06, Vol.18 (6), p.1077-1088

2017

Volltextzugriff (PDF)

Fibromyalgia syndrome

Journal of rheumatology, 2005-11, Vol.32 (11), p.2270

2005

Volltextzugriff (PDF)

Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users

Journal of clinical pharmacology, 2015-12, Vol.55 (12), p.1351-1361

2015

Volltextzugriff (PDF)

Evaluation of the effect of lasofoxifene (LASO) on the pharmacokinetics (PK) of digoxin

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P45-P45

2005

Volltextzugriff (PDF)

Pharmacokinetics (PK) of lasofoxifene (LASO), a next generation selective estrogen receptor modulator

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P85-P85

2005

Volltextzugriff (PDF)

A study of the effects of lasofoxifene (LASO) on the pharmacokinetics (PK) and pharmacodynamics (PD) of warfarin

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P47-P47

2005

Volltextzugriff (PDF)

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone

Clinical pharmacology in drug development, 2015-09, Vol.4 (5), p.370-376

2015

Volltextzugriff (PDF)

Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended-release oxycodone with sequestered naltrexone 40mg twice daily to oxycontin 40mg twice daily and extended-release oxycodone with sequestered naltrexone 80mg once daily

Clinical pharmacology in drug development, 2015-09, Vol.4 (5), p.361

2015

Volltextzugriff (PDF)

A Single-Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment

Journal of clinical pharmacology, 2006-01, Vol.46 (1), p.29-36

2006

Volltextzugriff (PDF)

Effect of Lasofoxifene on the Pharmacokinetics of Digoxin in Healthy Postmenopausal Women

Journal of clinical pharmacology, 2005-12, Vol.45 (12), p.1407-1412

2005

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(190)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(222)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(104)
Humans
(82)
Female
(54)
Animals
(42)
Biological And Medical Sciences
(42)
Male
(39)
Adult
(35)
Medical Sciences
(32)
Middle Aged
(25)
Mice
(24)
Infectious Diseases
(21)
Hiv
(20)
Immunology
(19)
Physical Sciences
(18)
Fundamental And Applied Biological Sciences. Psychology
(16)
Oncology
(15)
Adolescent
(14)
Human Immunodeficiency Virus
(14)
Medicine, Research & Experimental
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterization of nitrotyrosine as a biomarker for arthritis and joint injury

(413) Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability of extended-release oxycodone with sequestered naltrexone (ALO-02) in healthy volunteers: a comparison of ALO-02 40 mg twice daily to OxyContin 40 mg twice daily and ALO-02 80 mg once daily

(411) Abuse potential study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) compared with immediate-release oxycodone and placebo when crushed and administered intranasally to non-dependent, recreational opioid users

(409) Evaluation of the effects of food and of sprinkling pellets on applesauce on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended-release formulation of oxycodone with sequestered naltrexone

(410) Efficacy and safety of ALO-02, an extended-release oxycodone surrounding sequestered naltrexone, in the treatment of moderate-to-severe chronic low back pain

(412) Abuse potential study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) compared with immediate-release oxycodone administered orally to non-dependent, recreational opioid users

Efficacy and safety of tanezumab in the treatment of chronic low back pain

FRI0046 Characterization of nitrotyrosine as a clinical biomarker for arthritis and joint injury

Efficacy and safety of subcutaneous tanezumab in patients with pain related to diabetic peripheral neuropathy (NCT01087203)

Long-term safety and efficacy of tanezumab as treatment for chronic low back pain (NCT00924664)

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

Lack of a pharmacokinetic interaction between azithromycin and chloroquine

Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene

Tanezumab, an Anti-Nerve Growth Factor (NGF) antibody, for the treatment of chronic low back pain (CLBP) – a randomized, controlled, double-blind, phase 2 trial

A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users

Fibromyalgia syndrome

Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users

Evaluation of the effect of lasofoxifene (LASO) on the pharmacokinetics (PK) of digoxin

Pharmacokinetics (PK) of lasofoxifene (LASO), a next generation selective estrogen receptor modulator

A study of the effects of lasofoxifene (LASO) on the pharmacokinetics (PK) and pharmacodynamics (PD) of warfarin

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone

A Single-Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment

Effect of Lasofoxifene on the Pharmacokinetics of Digoxin in Healthy Postmenopausal Women

Suchergebnisse filtern